Beranda › Psoriasis › California › Fremont
Uji klinis Psoriasis di Fremont, CA
5 studi untuk Psoriasis mencari peserta di lokasi sekitar Fremont (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Menerima pesertaFase 3
- Vanda Investigational Site, Fremont
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Menerima pesertaFase 4
- Center For Dermatology Clinical Research, Inc., Fremont
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Menerima pesertaFase 3
- Center For Dermatology Clinical Research, Inc., Fremont
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Menerima pesertaFase 3
- Ppp001 50176, Fremont
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Menerima pesertaFase 2
- Study Center, Fremont
Uji klinis Psoriasis di kota lain
- Trenton, NJ7 studi
- Newton, MA6 studi
- Cleveland, OH6 studi
- Philadelphia, PA5 studi
- New York City, NY5 studi
- San Antonio, TX5 studi
- Huntington Beach, CA4 studi
- Birmingham, AL4 studi
- San Diego, CA3 studi
- Rochester, NY3 studi
- Columbus, OH3 studi
- Sacramento, CA3 studi
Studi lain di Fremont
- Kanker Paru7 studi
- Kanker Paru Non-Sel Kecil6 studi
- Kanker Payudara6 studi
- Kanker Prostat5 studi
- Dermatitis Atopik (Eksim)4 studi
- Penyakit Ginjal Kronis3 studi
- Kanker Pankreas3 studi
- Fibrilasi Atrium3 studi
- Gumpalan Darah3 studi
- Kanker Kolon3 studi
- Kanker Ovarium3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.